Pharmaceutical Commerce - March 2020
Dramatic growth tracks the flood of new specialty pharmaceuticals entering the market
ICER will expand use of RWE, as the Federal ONC calls for broader use of healthcare data
Clarivate Analytics predicts both approvals and commercial potential
A former executive at PhRMA, Davis will now lead the wholesaler-distributor association
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
2
The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection
3
A 'Beautiful Fake': Pharma Fraudsters Upping Their Game
4
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
5
